Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

Por um escritor misterioso

Descrição

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Regeneron on LinkedIn: Late-Breaking Dupixent® (dupilumab) Data at
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Frontiers Severe pediatric asthma therapy: Dupilumab
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
JCM, Free Full-Text
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Frontiers Severe pediatric asthma therapy: Dupilumab
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
International study supports dupilumab for treatment of moderate
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Developments in the Management of Severe Asthma in Children and
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Efficacy of dupilumab in asthma.
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
IL-4/13 blocker successful in treatment of paediatric moderate-to
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Dupilumab-improved lung function lasts in children with moderate
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Dupilumab in the management of moderate-to-severe asthma: the data
de por adulto (o preço varia de acordo com o tamanho do grupo)